Research Article

Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment

Figure 5

Risk group stratification with tumor characteristics. (a) Subgroup with BCLC C staging, (b) subgroup with BCLC D staging, (c) subgroup with largest tumor diameter <5 cm, and (d) subgroup with largest tumor diameter ≥5 cm. A subgroup of fewer than 10 patients was omitted from the figure.
(a)
(b)
(c)
(d)